Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment
Abstract This review aims to document difficulties, limitations, and pitfalls when considering protein analysis in blood samples. It proposes an improved workflow for design, development, and validation of (immuno)assays for blood proteins, without providing reflections on a potential hypothesis of...
Main Authors: | Hugo Marcel Vanderstichele, Charlotte E. Teunissen, Eugeen Vanmechelen |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-019-00166-3 |
Similar Items
-
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01) -
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01) -
Dual regulatory effects of neferine on amyloid-β and tau aggregation studied by in silico, in vitro, and lab-on-a-chip technology
by: Yunkwon Nam, et al.
Published: (2024-03-01) -
Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
by: Noemi Esteras, et al.
Published: (2020-09-01) -
Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
by: Yue Cai, et al.
Published: (2023-02-01)